nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—SLC22A3—Irinotecan—lung cancer	0.158	0.425	CbGbCtD
Norepinephrine—SLC22A2—Vinblastine—lung cancer	0.0833	0.224	CbGbCtD
Norepinephrine—SLC22A2—Cisplatin—lung cancer	0.0764	0.205	CbGbCtD
Norepinephrine—CYP1A2—Erlotinib—lung cancer	0.0316	0.0848	CbGbCtD
Norepinephrine—Injection site necrosis—Gemcitabine—lung cancer	0.0254	0.113	CcSEcCtD
Norepinephrine—CYP1A2—Etoposide—lung cancer	0.0228	0.0613	CbGbCtD
Norepinephrine—Gangrene—Gemcitabine—lung cancer	0.0122	0.0543	CcSEcCtD
Norepinephrine—Hypovolaemia—Irinotecan—lung cancer	0.00881	0.0392	CcSEcCtD
Norepinephrine—Photophobia—Crizotinib—lung cancer	0.00662	0.0295	CcSEcCtD
Norepinephrine—Pallor—Teniposide—lung cancer	0.0063	0.0281	CcSEcCtD
Norepinephrine—Extravasation—Teniposide—lung cancer	0.00599	0.0267	CcSEcCtD
Norepinephrine—Lactic acidosis—Doxorubicin—lung cancer	0.00483	0.0215	CcSEcCtD
Norepinephrine—Extravasation—Vinblastine—lung cancer	0.00457	0.0203	CcSEcCtD
Norepinephrine—Extravasation—Topotecan—lung cancer	0.00444	0.0198	CcSEcCtD
Norepinephrine—Extravasation—Vinorelbine—lung cancer	0.0038	0.0169	CcSEcCtD
Norepinephrine—Photophobia—Vinblastine—lung cancer	0.00374	0.0167	CcSEcCtD
Norepinephrine—Bradycardia—Crizotinib—lung cancer	0.00361	0.0161	CcSEcCtD
Norepinephrine—Arrhythmia—Crizotinib—lung cancer	0.00316	0.0141	CcSEcCtD
Norepinephrine—Extravasation—Irinotecan—lung cancer	0.00313	0.0139	CcSEcCtD
Norepinephrine—Extravasation—Gemcitabine—lung cancer	0.00305	0.0136	CcSEcCtD
Norepinephrine—Retrosternal pain—Doxorubicin—lung cancer	0.00292	0.013	CcSEcCtD
Norepinephrine—Arrhythmia—Pemetrexed—lung cancer	0.00289	0.0129	CcSEcCtD
Norepinephrine—Arrhythmia—Gefitinib—lung cancer	0.00287	0.0128	CcSEcCtD
Norepinephrine—Extravasation—Cisplatin—lung cancer	0.00284	0.0127	CcSEcCtD
Norepinephrine—Sweating—Teniposide—lung cancer	0.0028	0.0125	CcSEcCtD
Norepinephrine—Extravasation—Etoposide—lung cancer	0.0026	0.0116	CcSEcCtD
Norepinephrine—Extravasation—Paclitaxel—lung cancer	0.00255	0.0114	CcSEcCtD
Norepinephrine—Hypertension—Pemetrexed—lung cancer	0.00243	0.0108	CcSEcCtD
Norepinephrine—Chest pain—Pemetrexed—lung cancer	0.0024	0.0107	CcSEcCtD
Norepinephrine—Arrhythmia—Teniposide—lung cancer	0.00234	0.0104	CcSEcCtD
Norepinephrine—Dyspnoea—Crizotinib—lung cancer	0.00224	0.00999	CcSEcCtD
Norepinephrine—Blood pressure increased—Paclitaxel—lung cancer	0.00223	0.00992	CcSEcCtD
Norepinephrine—Extravasation—Docetaxel—lung cancer	0.00216	0.00963	CcSEcCtD
Norepinephrine—Sweating—Topotecan—lung cancer	0.00208	0.00924	CcSEcCtD
Norepinephrine—Dyspnoea—Pemetrexed—lung cancer	0.00205	0.00913	CcSEcCtD
Norepinephrine—Dyspnoea—Gefitinib—lung cancer	0.00204	0.00907	CcSEcCtD
Norepinephrine—Hypertension—Teniposide—lung cancer	0.00197	0.00878	CcSEcCtD
Norepinephrine—Chest pain—Teniposide—lung cancer	0.00194	0.00865	CcSEcCtD
Norepinephrine—Blood pressure increased—Docetaxel—lung cancer	0.00189	0.00841	CcSEcCtD
Norepinephrine—Hyperhidrosis—Teniposide—lung cancer	0.0018	0.00802	CcSEcCtD
Norepinephrine—Arrhythmia—Erlotinib—lung cancer	0.00172	0.00765	CcSEcCtD
Norepinephrine—Dyspnoea—Teniposide—lung cancer	0.00166	0.0074	CcSEcCtD
Norepinephrine—Vomiting—Crizotinib—lung cancer	0.0016	0.00713	CcSEcCtD
Norepinephrine—Extravasation—Methotrexate—lung cancer	0.00156	0.00694	CcSEcCtD
Norepinephrine—Hypertension—Vinblastine—lung cancer	0.0015	0.0067	CcSEcCtD
Norepinephrine—Arrhythmia—Vinorelbine—lung cancer	0.00149	0.00661	CcSEcCtD
Norepinephrine—Sweating—Irinotecan—lung cancer	0.00146	0.00652	CcSEcCtD
Norepinephrine—Vomiting—Pemetrexed—lung cancer	0.00146	0.00651	CcSEcCtD
Norepinephrine—Vomiting—Gefitinib—lung cancer	0.00145	0.00647	CcSEcCtD
Norepinephrine—Chest pain—Topotecan—lung cancer	0.00144	0.00641	CcSEcCtD
Norepinephrine—Sweating—Gemcitabine—lung cancer	0.00143	0.00635	CcSEcCtD
Norepinephrine—Chest pain—Erlotinib—lung cancer	0.00143	0.00635	CcSEcCtD
Norepinephrine—Anxiety—Erlotinib—lung cancer	0.00142	0.00632	CcSEcCtD
Norepinephrine—Bradycardia—Irinotecan—lung cancer	0.0014	0.00622	CcSEcCtD
Norepinephrine—Extravasation—Doxorubicin—lung cancer	0.00135	0.00601	CcSEcCtD
Norepinephrine—Hyperhidrosis—Topotecan—lung cancer	0.00134	0.00594	CcSEcCtD
Norepinephrine—Bradycardia—Cisplatin—lung cancer	0.00127	0.00564	CcSEcCtD
Norepinephrine—Hypertension—Vinorelbine—lung cancer	0.00125	0.00556	CcSEcCtD
Norepinephrine—Chest pain—Vinorelbine—lung cancer	0.00123	0.00549	CcSEcCtD
Norepinephrine—Dyspnoea—Topotecan—lung cancer	0.00123	0.00548	CcSEcCtD
Norepinephrine—Arrhythmia—Irinotecan—lung cancer	0.00123	0.00546	CcSEcCtD
Norepinephrine—Dyspnoea—Erlotinib—lung cancer	0.00122	0.00542	CcSEcCtD
Norepinephrine—Arrhythmia—Gemcitabine—lung cancer	0.00119	0.00531	CcSEcCtD
Norepinephrine—Vomiting—Teniposide—lung cancer	0.00118	0.00527	CcSEcCtD
Norepinephrine—Headache—Teniposide—lung cancer	0.00117	0.0052	CcSEcCtD
Norepinephrine—Bradycardia—Paclitaxel—lung cancer	0.00114	0.00507	CcSEcCtD
Norepinephrine—Arrhythmia—Cisplatin—lung cancer	0.00111	0.00495	CcSEcCtD
Norepinephrine—Dyspnoea—Vinorelbine—lung cancer	0.00105	0.00469	CcSEcCtD
Norepinephrine—Hypertension—Irinotecan—lung cancer	0.00103	0.00459	CcSEcCtD
Norepinephrine—Hypertension—Gemcitabine—lung cancer	0.001	0.00447	CcSEcCtD
Norepinephrine—Arrhythmia—Paclitaxel—lung cancer	0.000999	0.00445	CcSEcCtD
Norepinephrine—Chest pain—Gemcitabine—lung cancer	0.00099	0.00441	CcSEcCtD
Norepinephrine—Hyperhidrosis—Irinotecan—lung cancer	0.000942	0.00419	CcSEcCtD
Norepinephrine—Anxiety—Cisplatin—lung cancer	0.00092	0.00409	CcSEcCtD
Norepinephrine—Hyperhidrosis—Gemcitabine—lung cancer	0.000917	0.00409	CcSEcCtD
Norepinephrine—Vomiting—Vinblastine—lung cancer	0.000904	0.00402	CcSEcCtD
Norepinephrine—Headache—Vinblastine—lung cancer	0.000891	0.00397	CcSEcCtD
Norepinephrine—Vomiting—Topotecan—lung cancer	0.000878	0.00391	CcSEcCtD
Norepinephrine—Vomiting—Erlotinib—lung cancer	0.000869	0.00387	CcSEcCtD
Norepinephrine—Dyspnoea—Irinotecan—lung cancer	0.000869	0.00387	CcSEcCtD
Norepinephrine—Headache—Topotecan—lung cancer	0.000865	0.00385	CcSEcCtD
Norepinephrine—Hypertension—Etoposide—lung cancer	0.000857	0.00382	CcSEcCtD
Norepinephrine—Headache—Erlotinib—lung cancer	0.000856	0.00381	CcSEcCtD
Norepinephrine—Hyperhidrosis—Cisplatin—lung cancer	0.000855	0.00381	CcSEcCtD
Norepinephrine—Arrhythmia—Docetaxel—lung cancer	0.000847	0.00377	CcSEcCtD
Norepinephrine—Dyspnoea—Gemcitabine—lung cancer	0.000846	0.00377	CcSEcCtD
Norepinephrine—Chest pain—Etoposide—lung cancer	0.000845	0.00376	CcSEcCtD
Norepinephrine—Hypertension—Paclitaxel—lung cancer	0.000841	0.00374	CcSEcCtD
Norepinephrine—Chest pain—Paclitaxel—lung cancer	0.000829	0.00369	CcSEcCtD
Norepinephrine—Anxiety—Paclitaxel—lung cancer	0.000826	0.00368	CcSEcCtD
Norepinephrine—Dyspnoea—Cisplatin—lung cancer	0.000789	0.00351	CcSEcCtD
Norepinephrine—Hyperhidrosis—Etoposide—lung cancer	0.000783	0.00349	CcSEcCtD
Norepinephrine—Hyperhidrosis—Paclitaxel—lung cancer	0.000768	0.00342	CcSEcCtD
Norepinephrine—Vomiting—Vinorelbine—lung cancer	0.000751	0.00334	CcSEcCtD
Norepinephrine—Headache—Vinorelbine—lung cancer	0.00074	0.0033	CcSEcCtD
Norepinephrine—Sweating—Methotrexate—lung cancer	0.00073	0.00325	CcSEcCtD
Norepinephrine—Dyspnoea—Etoposide—lung cancer	0.000723	0.00322	CcSEcCtD
Norepinephrine—Hypertension—Docetaxel—lung cancer	0.000712	0.00317	CcSEcCtD
Norepinephrine—Dyspnoea—Paclitaxel—lung cancer	0.000708	0.00315	CcSEcCtD
Norepinephrine—Chest pain—Docetaxel—lung cancer	0.000703	0.00313	CcSEcCtD
Norepinephrine—Sweating—Doxorubicin—lung cancer	0.000632	0.00281	CcSEcCtD
Norepinephrine—Vomiting—Irinotecan—lung cancer	0.000619	0.00276	CcSEcCtD
Norepinephrine—Headache—Irinotecan—lung cancer	0.00061	0.00272	CcSEcCtD
Norepinephrine—Vomiting—Gemcitabine—lung cancer	0.000603	0.00269	CcSEcCtD
Norepinephrine—Bradycardia—Doxorubicin—lung cancer	0.000602	0.00268	CcSEcCtD
Norepinephrine—Dyspnoea—Docetaxel—lung cancer	0.0006	0.00267	CcSEcCtD
Norepinephrine—Headache—Gemcitabine—lung cancer	0.000595	0.00265	CcSEcCtD
Norepinephrine—Vomiting—Cisplatin—lung cancer	0.000562	0.0025	CcSEcCtD
Norepinephrine—Arrhythmia—Doxorubicin—lung cancer	0.000529	0.00235	CcSEcCtD
Norepinephrine—Vomiting—Etoposide—lung cancer	0.000515	0.00229	CcSEcCtD
Norepinephrine—Headache—Etoposide—lung cancer	0.000508	0.00226	CcSEcCtD
Norepinephrine—Chest pain—Methotrexate—lung cancer	0.000506	0.00225	CcSEcCtD
Norepinephrine—Vomiting—Paclitaxel—lung cancer	0.000505	0.00225	CcSEcCtD
Norepinephrine—Headache—Paclitaxel—lung cancer	0.000498	0.00222	CcSEcCtD
Norepinephrine—Hyperhidrosis—Methotrexate—lung cancer	0.000469	0.00209	CcSEcCtD
Norepinephrine—Hypertension—Doxorubicin—lung cancer	0.000445	0.00198	CcSEcCtD
Norepinephrine—Chest pain—Doxorubicin—lung cancer	0.000438	0.00195	CcSEcCtD
Norepinephrine—Anxiety—Doxorubicin—lung cancer	0.000437	0.00195	CcSEcCtD
Norepinephrine—Dyspnoea—Methotrexate—lung cancer	0.000433	0.00193	CcSEcCtD
Norepinephrine—Vomiting—Docetaxel—lung cancer	0.000428	0.00191	CcSEcCtD
Norepinephrine—Headache—Docetaxel—lung cancer	0.000422	0.00188	CcSEcCtD
Norepinephrine—Hyperhidrosis—Doxorubicin—lung cancer	0.000406	0.00181	CcSEcCtD
Norepinephrine—Dyspnoea—Doxorubicin—lung cancer	0.000375	0.00167	CcSEcCtD
Norepinephrine—Vomiting—Methotrexate—lung cancer	0.000309	0.00137	CcSEcCtD
Norepinephrine—Headache—Methotrexate—lung cancer	0.000304	0.00135	CcSEcCtD
Norepinephrine—Vomiting—Doxorubicin—lung cancer	0.000267	0.00119	CcSEcCtD
Norepinephrine—Headache—Doxorubicin—lung cancer	0.000263	0.00117	CcSEcCtD
Norepinephrine—SLC18A1—lymph node—lung cancer	0.000229	0.0803	CbGeAlD
Norepinephrine—ADRA1D—epithelium—lung cancer	0.000166	0.0583	CbGeAlD
Norepinephrine—SLC22A5—mammary gland—lung cancer	0.000156	0.0549	CbGeAlD
Norepinephrine—SLC6A2—respiratory system—lung cancer	0.000123	0.0431	CbGeAlD
Norepinephrine—ADRB1—bronchus—lung cancer	0.000119	0.0417	CbGeAlD
Norepinephrine—DRD2—respiratory system—lung cancer	0.000112	0.0393	CbGeAlD
Norepinephrine—SLC18A2—lung—lung cancer	0.000107	0.0375	CbGeAlD
Norepinephrine—SLC22A5—respiratory system—lung cancer	0.000104	0.0366	CbGeAlD
Norepinephrine—ADRB1—cardiac atrium—lung cancer	0.0001	0.0352	CbGeAlD
Norepinephrine—ADRA1A—epithelium—lung cancer	9.53e-05	0.0335	CbGeAlD
Norepinephrine—CYP1A2—respiratory system—lung cancer	9.43e-05	0.0331	CbGeAlD
Norepinephrine—ADRA2C—bronchus—lung cancer	8.94e-05	0.0314	CbGeAlD
Norepinephrine—SLC22A5—bronchus—lung cancer	8.57e-05	0.0301	CbGeAlD
Norepinephrine—ADRA2C—trachea—lung cancer	8.03e-05	0.0282	CbGeAlD
Norepinephrine—SLC22A5—trachea—lung cancer	7.69e-05	0.027	CbGeAlD
Norepinephrine—ADRB1—lung—lung cancer	7.66e-05	0.0269	CbGeAlD
Norepinephrine—SLC22A3—lung—lung cancer	7.6e-05	0.0267	CbGeAlD
Norepinephrine—ADRA2C—cardiac atrium—lung cancer	7.54e-05	0.0265	CbGeAlD
Norepinephrine—SLC18A2—lymph node—lung cancer	7.3e-05	0.0257	CbGeAlD
Norepinephrine—SLC22A5—cardiac atrium—lung cancer	7.23e-05	0.0254	CbGeAlD
Norepinephrine—ADRA2A—bronchus—lung cancer	7.14e-05	0.0251	CbGeAlD
Norepinephrine—SLC6A2—lung—lung cancer	6.51e-05	0.0229	CbGeAlD
Norepinephrine—ADRA2A—trachea—lung cancer	6.41e-05	0.0225	CbGeAlD
Norepinephrine—ADRA2A—cardiac atrium—lung cancer	6.02e-05	0.0212	CbGeAlD
Norepinephrine—DRD2—lung—lung cancer	5.94e-05	0.0209	CbGeAlD
Norepinephrine—ADRA2C—lung—lung cancer	5.77e-05	0.0203	CbGeAlD
Norepinephrine—SLC22A5—lung—lung cancer	5.53e-05	0.0194	CbGeAlD
Norepinephrine—SLC22A3—lymph node—lung cancer	5.2e-05	0.0183	CbGeAlD
Norepinephrine—CYP1A2—lung—lung cancer	5.01e-05	0.0176	CbGeAlD
Norepinephrine—ADRA2A—lung—lung cancer	4.6e-05	0.0162	CbGeAlD
Norepinephrine—SLC6A2—lymph node—lung cancer	4.46e-05	0.0157	CbGeAlD
Norepinephrine—ADRA2C—lymph node—lung cancer	3.95e-05	0.0139	CbGeAlD
Norepinephrine—SLC22A5—lymph node—lung cancer	3.78e-05	0.0133	CbGeAlD
Norepinephrine—ADRA2A—lymph node—lung cancer	3.15e-05	0.0111	CbGeAlD
Norepinephrine—ADRA2B—Signaling Pathways—JUN—lung cancer	8.59e-06	2.15e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—HRAS—lung cancer	8.57e-06	2.14e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—TYMS—lung cancer	8.56e-06	2.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SRC—lung cancer	8.53e-06	2.13e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCND1—lung cancer	8.5e-06	2.12e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CXCL8—lung cancer	8.49e-06	2.12e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—EP300—lung cancer	8.48e-06	2.12e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—JUN—lung cancer	8.48e-06	2.12e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GSTM1—lung cancer	8.46e-06	2.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—HRAS—lung cancer	8.44e-06	2.11e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MMP9—lung cancer	8.43e-06	2.11e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAP2K1—lung cancer	8.42e-06	2.1e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—PIK3CA—lung cancer	8.41e-06	2.1e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CDKN1A—lung cancer	8.4e-06	2.1e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PTEN—lung cancer	8.38e-06	2.09e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MDM2—lung cancer	8.37e-06	2.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CD—lung cancer	8.37e-06	2.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MMP9—lung cancer	8.35e-06	2.09e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RAF1—lung cancer	8.34e-06	2.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AKT1—lung cancer	8.34e-06	2.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CDKN1A—lung cancer	8.32e-06	2.08e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—lung cancer	8.31e-06	2.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PTEN—lung cancer	8.31e-06	2.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—PIK3CA—lung cancer	8.29e-06	2.07e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CASP3—lung cancer	8.26e-06	2.06e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ERBB2—lung cancer	8.26e-06	2.06e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MMP9—lung cancer	8.25e-06	2.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL2—lung cancer	8.25e-06	2.06e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—STAT3—lung cancer	8.23e-06	2.06e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CDKN1A—lung cancer	8.22e-06	2.05e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NRAS—lung cancer	8.21e-06	2.05e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL6—lung cancer	8.2e-06	2.05e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AKT1—lung cancer	8.2e-06	2.05e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PTEN—lung cancer	8.2e-06	2.05e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—KRAS—lung cancer	8.19e-06	2.05e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AKT1—lung cancer	8.18e-06	2.04e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CB—lung cancer	8.15e-06	2.04e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MTOR—lung cancer	8.15e-06	2.04e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AKT1—lung cancer	8.14e-06	2.03e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CASP3—lung cancer	8.13e-06	2.03e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL2—lung cancer	8.12e-06	2.03e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AKT1—lung cancer	8.1e-06	2.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	8.1e-06	2.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL6—lung cancer	8.07e-06	2.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MDM2—lung cancer	8.07e-06	2.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RAF1—lung cancer	8.04e-06	2.01e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCND1—lung cancer	8.04e-06	2.01e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CYP1A1—lung cancer	8.02e-06	2e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—JUN—lung cancer	8.02e-06	2e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AKT1—lung cancer	8e-06	2e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EP300—lung cancer	7.99e-06	2e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ERCC2—lung cancer	7.96e-06	1.99e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ERBB2—lung cancer	7.95e-06	1.99e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EP300—lung cancer	7.92e-06	1.98e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCND1—lung cancer	7.91e-06	1.98e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—JUN—lung cancer	7.89e-06	1.97e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MAPK3—lung cancer	7.86e-06	1.96e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	7.85e-06	1.96e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MTOR—lung cancer	7.85e-06	1.96e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CXCL8—lung cancer	7.83e-06	1.96e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EP300—lung cancer	7.82e-06	1.95e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MMP9—lung cancer	7.8e-06	1.95e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—HRAS—lung cancer	7.78e-06	1.94e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CDKN1A—lung cancer	7.78e-06	1.94e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SRC—lung cancer	7.77e-06	1.94e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PTEN—lung cancer	7.76e-06	1.94e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SRC—lung cancer	7.7e-06	1.92e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MMP9—lung cancer	7.68e-06	1.92e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN1A—lung cancer	7.65e-06	1.91e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MYC—lung cancer	7.65e-06	1.91e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PTEN—lung cancer	7.64e-06	1.91e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SRC—lung cancer	7.6e-06	1.9e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—lung cancer	7.57e-06	1.89e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AKT1—lung cancer	7.57e-06	1.89e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AKT1—lung cancer	7.56e-06	1.89e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CXCL8—lung cancer	7.54e-06	1.88e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PTEN—lung cancer	7.54e-06	1.88e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	7.53e-06	1.88e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—lung cancer	7.5e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—STAT3—lung cancer	7.5e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MDM2—lung cancer	7.5e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—HRAS—lung cancer	7.49e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CASP3—lung cancer	7.49e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL2—lung cancer	7.48e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NRAS—lung cancer	7.48e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—EGFR—lung cancer	7.48e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RAF1—lung cancer	7.47e-06	1.87e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AKT1—lung cancer	7.45e-06	1.86e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL6—lung cancer	7.44e-06	1.86e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—STAT3—lung cancer	7.43e-06	1.86e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NRAS—lung cancer	7.41e-06	1.85e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—lung cancer	7.41e-06	1.85e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EP300—lung cancer	7.4e-06	1.85e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ERBB2—lung cancer	7.39e-06	1.85e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—STAT3—lung cancer	7.33e-06	1.83e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NRAS—lung cancer	7.32e-06	1.83e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCND1—lung cancer	7.29e-06	1.82e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	7.29e-06	1.82e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MTOR—lung cancer	7.29e-06	1.82e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	7.29e-06	1.82e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EP300—lung cancer	7.28e-06	1.82e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—JUN—lung cancer	7.28e-06	1.82e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CASP3—lung cancer	7.22e-06	1.8e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL2—lung cancer	7.21e-06	1.8e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SRC—lung cancer	7.2e-06	1.8e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—EP300—lung cancer	7.19e-06	1.8e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—IL6—lung cancer	7.17e-06	1.79e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MAPK3—lung cancer	7.16e-06	1.79e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MAPK3—lung cancer	7.1e-06	1.77e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SRC—lung cancer	7.08e-06	1.77e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MMP9—lung cancer	7.08e-06	1.77e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—KRAS—lung cancer	7.06e-06	1.77e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN1A—lung cancer	7.06e-06	1.76e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PTEN—lung cancer	7.04e-06	1.76e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCND1—lung cancer	7.03e-06	1.76e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—JUN—lung cancer	7.01e-06	1.75e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCL8—lung cancer	7.01e-06	1.75e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—lung cancer	7.01e-06	1.75e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MAPK3—lung cancer	7.01e-06	1.75e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MYC—lung cancer	6.97e-06	1.74e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—HRAS—lung cancer	6.96e-06	1.74e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—STAT3—lung cancer	6.94e-06	1.73e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NRAS—lung cancer	6.92e-06	1.73e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MYC—lung cancer	6.9e-06	1.72e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—lung cancer	6.9e-06	1.72e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—APOA1—lung cancer	6.88e-06	1.72e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AKT1—lung cancer	6.87e-06	1.72e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—STAT3—lung cancer	6.83e-06	1.71e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MMP9—lung cancer	6.82e-06	1.7e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MYC—lung cancer	6.81e-06	1.7e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EGFR—lung cancer	6.81e-06	1.7e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NRAS—lung cancer	6.81e-06	1.7e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	6.8e-06	1.7e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PTEN—lung cancer	6.78e-06	1.69e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	6.77e-06	1.69e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EGFR—lung cancer	6.75e-06	1.69e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PIK3CA—lung cancer	6.73e-06	1.68e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EP300—lung cancer	6.71e-06	1.68e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CASP3—lung cancer	6.71e-06	1.68e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL2—lung cancer	6.7e-06	1.67e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EGFR—lung cancer	6.67e-06	1.67e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL6—lung cancer	6.66e-06	1.67e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MAPK3—lung cancer	6.63e-06	1.66e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	6.62e-06	1.65e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.59e-06	1.65e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PIK3CA—lung cancer	6.55e-06	1.64e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCND1—lung cancer	6.53e-06	1.63e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SRC—lung cancer	6.53e-06	1.63e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	6.52e-06	1.63e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—JUN—lung cancer	6.52e-06	1.63e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PIK3CA—lung cancer	6.49e-06	1.62e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EP300—lung cancer	6.47e-06	1.62e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MYC—lung cancer	6.45e-06	1.61e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—KRAS—lung cancer	6.44e-06	1.61e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—KRAS—lung cancer	6.38e-06	1.59e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—lung cancer	6.36e-06	1.59e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MYC—lung cancer	6.35e-06	1.59e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MMP9—lung cancer	6.34e-06	1.58e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	6.32e-06	1.58e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EGFR—lung cancer	6.31e-06	1.58e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PTEN—lung cancer	6.3e-06	1.57e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—KRAS—lung cancer	6.3e-06	1.57e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—STAT3—lung cancer	6.3e-06	1.57e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SRC—lung cancer	6.29e-06	1.57e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CG—lung cancer	6.28e-06	1.57e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NRAS—lung cancer	6.28e-06	1.57e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TP53—lung cancer	6.28e-06	1.57e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PIK3CA—lung cancer	6.27e-06	1.57e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EGFR—lung cancer	6.21e-06	1.55e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	6.15e-06	1.54e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	6.13e-06	1.53e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—STAT3—lung cancer	6.07e-06	1.52e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NRAS—lung cancer	6.05e-06	1.51e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MAPK3—lung cancer	6.02e-06	1.5e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EP300—lung cancer	6.01e-06	1.5e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HRAS—lung cancer	6e-06	1.5e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—POMC—lung cancer	5.98e-06	1.49e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—KRAS—lung cancer	5.96e-06	1.49e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PIK3CA—lung cancer	5.91e-06	1.48e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—KRAS—lung cancer	5.86e-06	1.47e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PIK3CA—lung cancer	5.86e-06	1.46e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MYC—lung cancer	5.85e-06	1.46e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SRC—lung cancer	5.84e-06	1.46e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CREBBP—lung cancer	5.83e-06	1.46e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	5.8e-06	1.45e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PIK3CA—lung cancer	5.78e-06	1.45e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6—lung cancer	5.75e-06	1.44e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EGFR—lung cancer	5.72e-06	1.43e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TP53—lung cancer	5.72e-06	1.43e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	5.69e-06	1.42e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TP53—lung cancer	5.67e-06	1.42e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MYC—lung cancer	5.64e-06	1.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—STAT3—lung cancer	5.64e-06	1.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NRAS—lung cancer	5.62e-06	1.4e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TP53—lung cancer	5.6e-06	1.4e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CD—lung cancer	5.52e-06	1.38e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EGFR—lung cancer	5.51e-06	1.38e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—AKT1—lung cancer	5.5e-06	1.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PIK3CA—lung cancer	5.47e-06	1.37e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HRAS—lung cancer	5.47e-06	1.37e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ALB—lung cancer	5.45e-06	1.36e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HRAS—lung cancer	5.42e-06	1.35e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—KRAS—lung cancer	5.41e-06	1.35e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	5.39e-06	1.35e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	5.38e-06	1.35e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HRAS—lung cancer	5.35e-06	1.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—AKT1—lung cancer	5.35e-06	1.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PIK3CA—lung cancer	5.32e-06	1.33e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AKT1—lung cancer	5.3e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TP53—lung cancer	5.3e-06	1.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MYC—lung cancer	5.24e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6—lung cancer	5.24e-06	1.31e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TP53—lung cancer	5.21e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—KRAS—lung cancer	5.21e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6—lung cancer	5.19e-06	1.3e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—AKT1—lung cancer	5.12e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IL6—lung cancer	5.12e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EGFR—lung cancer	5.12e-06	1.28e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HRAS—lung cancer	5.06e-06	1.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HRAS—lung cancer	4.98e-06	1.25e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PIK3CA—lung cancer	4.97e-06	1.24e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6—lung cancer	4.85e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—KRAS—lung cancer	4.84e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AKT1—lung cancer	4.83e-06	1.21e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CB—lung cancer	4.81e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TP53—lung cancer	4.8e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AKT1—lung cancer	4.79e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	4.78e-06	1.2e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTGS2—lung cancer	4.77e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6—lung cancer	4.77e-06	1.19e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AKT1—lung cancer	4.73e-06	1.18e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TP53—lung cancer	4.63e-06	1.16e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HRAS—lung cancer	4.59e-06	1.15e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AKT1—lung cancer	4.47e-06	1.12e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	4.45e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HRAS—lung cancer	4.43e-06	1.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AKT1—lung cancer	4.4e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6—lung cancer	4.4e-06	1.1e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AKT1—lung cancer	4.34e-06	1.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TP53—lung cancer	4.3e-06	1.07e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6—lung cancer	4.24e-06	1.06e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PTEN—lung cancer	4.16e-06	1.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HRAS—lung cancer	4.11e-06	1.03e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AKT1—lung cancer	4.06e-06	1.01e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—EP300—lung cancer	3.97e-06	9.91e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6—lung cancer	3.94e-06	9.84e-06	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AKT1—lung cancer	3.91e-06	9.77e-06	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AKT1—lung cancer	3.63e-06	9.08e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3CA—lung cancer	2.94e-06	7.33e-06	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AKT1—lung cancer	2.4e-06	5.99e-06	CbGpPWpGaD
